NCT00609466View on ClinicalTrials.gov

A Trial to Evaluate CG5503 Efficacy and Safety in Acute Pain After Bunionectomy

PHASE3CompletedINTERVENTIONAL
Enrollment

291

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
BunionectomyPainPostoperative PainAcute Pain
Interventions
DRUG

CG5503 IR

75mg IR 4 - 6 hourly Total: 72 hours

DRUG

Morphine

Morphine 30 mg IR 4 - 6 hourly Total: 72 hours

DRUG

Placebo

Placebo; 4 - 6 hourly; Total: 72 hours

Trial Locations (6)

21122

Site 104, Pasadena

77081

Site 102, Houston

78229

Site 105, San Antonio

78666

Site 103, San Marcos

78705

Site 101, Austin

84117

Site 106, Salt Lake City

Sponsors

Lead Sponsor

Grünenthal GmbH
All Listed Sponsors
collaborator

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

lead

Grünenthal GmbH

INDUSTRY

NCT00609466 - A Trial to Evaluate CG5503 Efficacy and Safety in Acute Pain After Bunionectomy | Biotech Hunter | Biotech Hunter